Sarepta Therapeutics
SRPT
#2202
Rank
โ‚ฌ6.30 B
Marketcap
65,01ย โ‚ฌ
Share price
-1.95%
Change (1 day)
-46.02%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): โ‚ฌ0.24 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ1.90 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ0.49 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.24 B-150.14%
2023 -โ‚ฌ0.49 Billion-24.62%
2022 -โ‚ฌ0.64 Billion64.69%
2021 -โ‚ฌ0.39 Billion-24.25%
2020 -โ‚ฌ0.52 Billion-22.53%
2019 -โ‚ฌ0.66 Billion96.87%
2018 -โ‚ฌ0.34 Billion645.68%
2017 -โ‚ฌ44.9 Million-81.81%
2016 -โ‚ฌ0.25 Billion21.47%
2015 -โ‚ฌ0.21 Billion62.04%
2014 -โ‚ฌ0.13 Billion21.26%
2013 -โ‚ฌ0.11 Billion60.93%
2012 -โ‚ฌ64.25 Million93.69%
2011 -โ‚ฌ33.18 Million71.58%
2010 -โ‚ฌ19.34 Million35.06%
2009 -โ‚ฌ14.32 Million-11.62%
2008 -โ‚ฌ16.2 Million-47.02%
2007 -โ‚ฌ30.57 Million0.38%
2006 -โ‚ฌ30.46 Million88.3%
2005 -โ‚ฌ16.18 Million-30.06%
2004 -โ‚ฌ23.13 Million32.69%
2003 -โ‚ฌ17.43 Million-25.52%
2002 -โ‚ฌ23.4 Million64.52%
2001 -โ‚ฌ14.23 Million50.4%
2000 -โ‚ฌ9.46 Million26.44%
1999 -โ‚ฌ7.48 Million8%
1998 -โ‚ฌ6.93 Million102.7%
1997 -โ‚ฌ3.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ0.63 B 164.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.15 Billion-160.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.3 Billion-223.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ80.29 Million-133.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.22 Billion-190.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.34 Billion-239.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.77 Billion-418.21%๐Ÿ‡บ๐Ÿ‡ธ USA